Colon cancer remains a major threat to human life. In 2012, 103 170 new cases of colon cancer were diagnosed and 51 690 deaths occurred from colorectal cancer in the United States. 1 Although the rate ...
The topical chemotherapeutic drug 5-fluorouracil (5-FU) was more effective at treating high-grade vaginal intraepithelial neoplasia (VIN) than surgical excision or laser ablation, according to results ...
Cost-effectiveness of three years of adjuvant imatinib in gastrointestinal stromal tumors (GIST). Background: 5-FU induced encephalopathy was known as uncommon toxicity during the treatment which ...
Omitting bolus 5-fluorouracil (5-FU) from combination chemotherapy for gastrointestinal (GI) cancers did not adversely affect survival and was associated with less toxicity, a review of a large ...
SAN FRANCISCO — The first and only antidote for a chemotherapy overdose appears to be a safe and effective life-saving emergency treatment. The product, uridine triacetate (Vistogard, Wellstat ...
Barriers to symptom management in oncology. Background: 5-fluorouracil (5-FU) is widely used to treat solid tumors and is often administered via infusion pump at or near its maximum tolerated dose.
The FDA highlights increased toxicity risks in patients with DPD deficiency when using Xeloda and 5-FU, urging genetic testing before treatment. DPD deficiency leads to severe side effects from ...
Fluorouracil (5 -Fu-Korea) is an antimetabolite, prescribed for certain types of cancer such as colon, rectal, breast, stomach and pancreatic cancer. It works by blocking the growth of certain cells.
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Administration of 5-FU bolus did not affect survival for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results